glutathione and nerves Potentiation of loss nerve cell death by the transition metals iron and copper: Implications for age-related neurodegenerative diseases The Glutamate–Glutathione axis in neuropsychiatric
Description
Here's where it gets interesting

The FDA does not approve compounded medications for safety, quality, or manufacturing

This demonstrates the therapeutic potential of the combined approach for the treatment of age-related liver failure as well as NAFLD

Common adverse effects: Injection site reactions: Pain, redness, swelling, or bruising at the injection site are frequently reported
